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This work aimed to investigate the effect of acute and chronic administration of gold nanoparticles (GNPs) on liver and 
kidney functions, blood glucose concentration, lipid profile, and haematological parameters in male albino rats. Two 
experiments were conducted. In acute study: Fifty-four adult mature male rats were randomly assigned into three equal 
groups (18 per group). Group 1 (control group): in which rats were received intramuscular (i.m) injection of  
1 ml normal saline 0.9%. Group 2 (50 nm GNPs group): rats were i.m. injected with a single dose of 75 µg 50 nm GNPs/kg 
body weight (bwt). In Group 3 (10 nm GNPs group): rats were i.m. injected with a single dose of 75 µg 10 nm GNPs/kg 
bwt. In chronic study: Eighteen adult male rats were randomly divided into three equal groups (6 per group). Group І 
(control): rats were intramuscular (i.m) repeatedly injected with 1 ml normal saline 0.9% once/week 5 for weeks. Group 2  
(50 nm GNPs): rats were i.m. injected with once/week with a dose of 75 µg 50 nm GNPs/kg bwt) for 5 weeks. In Group 3 
(10 nm GNPs): male rats were i.m. injected with once/week with a dose of 75 µg 50 nm GNPs/kg bwt for 5 weeks, followed 
by 3 weeks washout period for all groups. Blood was collected at 3, 7, and 60 days in acute experiment, while, they were 
collected only before and after 2 months in chronic experiment. Acute and chronic administration of GNPs (10 or  
50 nm size) in male albino rats induced no significant alterations for liver and kidney functions, lipid profile parameters and 
different haematological parameters at days 3 and 60 of the study. However, on day-7 post-treatment, GNPs-treated rats 
showed significantly (P <0.05) higher serum ALT, AST, ALP, urea, creatinine, glucose, and different lipid profile and 
decreased HDL level. Chronic administration of 10 nm or 50 nm GNPs significantly (P <0.05) decreased serum glucose 
levels. In conclusion acute or chronic administration of 10 nm or 50 nm GNPs could alter the liver, kidney functions and 
blood profile on day 7 post-treatment, however, these values returned to the normal levels on day 60 post- injection. Also, 
the chronic administration of GNPs induced a hypoglycemic effect in male albino rats. 
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Nanotechnology is a new technological field that 
benefits from the unique characteristics of particles in 
nano dimensions. It is widely used in biomedical and 
many industries applications1. Gold nanoparticles 
(AuNPs) which are easily modified in size, shape, and 
functionalization, are among the most prominent 
inorganic nanoparticles2. Nanoparticles have anticancer 
activity against neuroblastoma cells3. The combination 
of biotechnology and nanotechnology has encouraged 
the rapid development of fungal extracellular enzyme 
cocktail through nanoencapsulation4.  
Recently, AuNPs have a wide range of applications in 
medicine, catalysis, diagnostics, sensors5, and different 
industries such as beverages, toothpaste, vehicles, air 
handling units6, as well as nanomedicine, drug delivery, 
diagnosis, gene therapy, photothermal therapy, 
radiotherapy, biosensing, as well as cancer diagnosis 
and therapy7-9. 
The extensive use of AuNPs in biomedical and 
industrial fields has raised the significant concerns 
about their capacity to impair human health.  
Some reports have recorded that exposure to AuNPS  
is toxic6,10. On the other hand, other studies have 
reported that AuNPs are not toxic11,12. The toxicity  
and distribution of AuNPs are based on their 
physicochemical properties such as size, shape, surface 
composition and chemistry (such as coating)13, 
techniques for synthesis, exposure duration, and a dose 
of gold nanoparticle and route of administration14. 
It has been proven that smaller gold particles are 
more toxic than larger particles. This may be because the 
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interactions which are often linked to their 
physiochemical feature between smaller AuNPs and 
biological systems that allow them to be internalized 
within cells than larger particles15. Some researchers 
indicated that gold nanorods (AuNRs) are more  
toxic than gold nanospheres (AuNSs)16. Also, the 
frequency of administration affected the toxicity of 
AuNPs, chronic administration of GNPs at size 10 and 
30 nm resulted in higher DNA damage than their acute 
administration17. 
It has been shown that the main mechanism of the 
toxicity of AuNPs is through oxidative stress and via 
inflammatory response18.On the other hand, other 
experimenters demonstrated no significant induction 
of oxidative stress or inflammatory response since 
GNPs are potential antioxidants, GNPs influenced 
catalase enzyme to reduce the oxidative stress in 
tissues19 and efficient for quenching ROS, including 
hydrogen peroxide (H2O2) and superoxide anion 
radical (O.2) in a dose-dependent manner20,21. 
Here we focus our attention on studying the acute 
and chronic effects of GNPs on the liver, and kidney 
functions, blood glucose concentration, lipid profile, 
and hematological parameters. 
 
Materials and Methods 
Gold nanoparticles (GNPs) at size 10 nm were 
purchased from Sigma-Aldrich Com., Germany 
(PCode: 4100798324). While, GNPs solution at size 
50 nm was prepared according to the method adopted 
by Turkevich22.  
 
Experimental design 
Seventy-two mature male albino Wister rats  
(110-150 g/bwt) were obtained from AL-Zyade 
Experimental Animals Production Center, Giza, Egypt. 
They were kept in well-ventilated metal cages at  
23 ± 2°C, 40–60% relative humidity, and light/dark 
cycle of 12 h. The composition of the diet was as 
follows for 1 kg: corn starch, 620.7 g; mineral mixture 
(AIN-93M-MX), 35 g; casein (85%protein),140 g; 
mineral mixture(AIN-93M-VX), 10 g; sucrose, 100 g; 
L-cysteine, 1.8 g; soybean oil, 40 g; choline chloride, 
2.5 g; fiber, 50 g; tetra-butyl-hydroquinone, 0.008 g. 
Water was supplied ad-libitum all over the study and 
the rats were left 2 weeks for adaptation. 
Rats were random divided into two experiments for 
evaluation of the effect of acute and chronic effects of 
gold nanoparticles (GNPs) (10 and 50 nm size). 
Experiment 1: To evaluate the acute effect of 10 
or 50 nm GNPs on liver, kidney functions, and blood 
profile in male rats. Animals were assigned into 3 
groups: 
Group 1 (control group): Eighteen rats were 
received IM injection of 1 mL normal saline 0.9%. 
Group 2 (10 nm GNPs): Eighteen rats in each 
group were received a single dose of 75 μg 10 nm 
GNPs/kg/bwt, i.m. according to Abdoon et al.7. 
Group 3 (50 nm GNPs): Eighteen male rats in 
each group were received a single i.m. dose of 75 μg 
10 nm GNPs/kg/bwt. Rats were weighed weekly and 
6 rats from each group were scarificed under 
anesthesia by diethyl ether after 3, 7 and 60 days. 
Experiment II: To evaluate the chronic effect of 
10 or 50 nm GNPS on the liver, kidney functions and 
blood profile in male rats. Animals were allocated 
into 3 groups: 
Group 1 (control group): Six rats were fed on a 
basal diet, normal water, and i.m. injected with 1 mL 
saline solution every week and for 5 weeks, followed 
by 3 weeks of observation. 
Group 2 (GNPs at size 10 nm size): Six rats in 
each group were administered 75 μg 10 nm 
GNPs/kg/bwt once weekly for successive five weeks 
followed by a 21-day washout period.  
Group 3 (GNPs at size 50 nm size): Six rats in 
each group were administered 75 μg 10 nm 
GNPs/kg/bwt once weekly for successive five weeks, 
followed by a 21 day washout period. Rats were 
weighed weekly and at the end of the experiment; 
they were scarificed under anesthesia by diethyl ether. 
 
Blood sample collection, biochemical and hematological 
analyses 
Three blood samples were collected. The first 
blood was collected on EDTA vacutainer tube for 
analysis of blood profile. Second blood samples were 
collected on plan vacutainer tube (without EDTA)  
for biochemical analysis. Blood was centrifuged at 
1000 g for 15 min and clear serum samples were 
separated and stored at –20°C until biochemical 
analysis. The third part of the blood was collected in a 
tube containing sodium florid for measuring blood 
glucose concentration. 
For biochemical analysis, serum levels for liver 
function were measured spectrophotometrically using 
Human company kits for ALT and AST23and alkaline 
phosphatase (ALP) by using Spectrum kits24. Kidney 
functions were measured spectrophotometrically 
using Diamond kits for urea concentration25 and 
creatinine26 by using Spin react kits. Blood glucose 
concentration was measured by using Spin react 
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kits27. Determination of serum lipid profile including 
cholesterol (TC) concentration was measured by  
using Spin react kits28, triglycerides (TAG) level was 
determined colorimetrically by using Spin react kits26. 
High-density lipoprotein-cholesterol concentration was 
determined by using Cholesterol HDL precipitating 
reagent kits, BioSystem29, Low-density lipoprotein and 
very-low density lipoprotein were calculated as 
described by Friedewald et al.30 as follows: 
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For hematological analysis: Hematological 
autoanalyzer (BeneSpheraTM H32 VET 3-Part 
Differential Hematology Analyzer User’s Manual, 
3477 Corporate Parkway, Suite 3 200 Center Valley, 
PA18034 (USA) was used to determine hematological 
parameters. 
 
Statistical analysis 
All data were presented as mean ± standard errors 
(SE). Statistical significances of the different sizes of 
gold nanoparticles were determined by one way 
ANOVA31.All statistical analysis was performed 
using SPSS (Statistical Package for Social Sciences) 
Version 22. 
 
Results 
Effects of GNPs on biochemical parameters analyses 
Data illustrated in (Fig. 1), represent the effect of 
acute and chronic i.m. injection of 75 μg GNPs/kg/bwt 
on different serum biochemical parameters. Results 
indicated that i.m. injection of a single dose of 75 μg  
50 nm GNPs/kg/bwt to male rats had no significant 
effect on serum ALT, AST, ALP activities, urea, 
creatinine levels, and blood glucose concentration 
 
 
Fig. 1 — Acute and chronic effects of GNPs on different biochemical parameters after 3, 7 and 60 days in different groups of rats after 
(A) 3; (B) 7; (C) 60 days; and (D) chronic effect 
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compared to control group after 3, 7 and 60 days. 
However, i.m. injection of a single dose of 75 μg  
10 nm GNPs/kg/bwt significantly (P <0.05) increased 
of serum ALT, AST, ALP activities and urea level 
compared to the control group on day 7 post-treatment. 
Also, results in (Fig. 1) indicated that repeated 
administration of 75 μg 10 nm or 50 nm GNPs/kg/bwt 
has no significant effect on serum ALT, AST activities, 
urea, creatinine, levels. While they significantly reduced 
serum ALP activity and significantly (P <0.05) 
decreased blood glucose concentration on Day-60  
post-treatment compared to the control group.  
 
Effects of GNPs on serum lipid profile 
Data illustrated in (Fig. 2), represent the effect of 
acute and chronic administration of 75 μg GNPs/kg/ 
bwt on serum lipid profile. Results reported that  
i.m. injection of a single dose of 75 μg 50 nm 
GNPs/kg/bwt to male rats had no significant effect  
on serum TC, TAG, HDL, non-HDL cholesterol  
(LDL-VLDL) levels compared to the control group 
after 3, 7 and 60 days. However, the acute treatment 
with 10 nm GNPs significantly (P <0.05) increased 
serum TC, TAG, LDL, and VLDL levels but they 
significantly decreased serum HDL level compared to 
the control group on Day-7 post-injection. 
As well as, results in (Fig. 2) reported that chronic 
administration of 10 nm or 50 nm GNPs has no 
significant effect on serum TC, TAG, HDL, LDL, and 
VLDL levels on Day-60 post-treatment compared to 
the control group.  
 
 
Fig. 2 — Effect of acute and chronic injection of 10 nm or 50 nm GNPs on serum lipid profile after (A) 3; (B) 7; (C) 60 days; and (D) 
chronic effect in different groups of rats 
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Effects of GNPs on hematological analysis 
Data illustrated in (Fig. 3), represent the acute and 
chronic effects of i.m. injection of 75 μg 10 nm or  
50 nm GNPs/kg/bwt on various hematological 
parameters. For hematological analysis, i.m. injection 
of single or repeated doses of 10 nm or 50 nm GNPs 
has no significant effect on any of the tested 
hematological parameters such as RBC, HGB, PCV, 
MCV, MCH, MCHC, WBC, and PLT compared to the 
control group at any time point of the experiment. 
However, repeated i.m. injection of 50 nm GNPs 
significantly (P <0.05) decreased platelets count on Day-
60 post-treatment when compared to the control group. 
 
Discussion 
GNPs have been extensively used in many medical 
applications. The health impact of exposure to GNPs 
on various biochemical and hematological parameters 
in rats must be assessed. 
The possible toxic effects of GNPs in the present 
work were confirmed through the analysis of different 
biochemical and hematological parameters. With 
regard to the estimation of liver and kidney functions, 
on Day-3 after i.m. injection of single doses of 75 μg of 
50 nm or 10 nm GNPs/kg bwt in male rats, no adverse 
effects on activities of ALT, AST, urea and creatinine 
levels were detected in 10 nm and 50 nm GNPs 
treated groups when compared with control one, 
however, Day-7 post-injection which showed significant 
increase of serum activities of ALT, AST and urea level, 
however, these values were returned to normal levels on 
Day- 60 post-injection. Also, in this work, repeated 
injection of 75 μg of 10 or 50 nm GNPS/kg bwt in male 
 
 
Fig. 3 — Effect of acute and chronic injection of 10 nm or 50 nm GNPs on haematology after (A) 3; (B) 7; (C) 60 days; and (D) chronic 
effect in male rats 
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rats for 5 weeks did not elicit any changes in liver or 
kidney functions 60 days after injection. 
In similar, some studies reported that repeated 
injection of 0.9, 9 and 90 µg of 14 nm AuNPs 0.9, 9 
and 90 µg does not effect on ALP, ALT, total bilirubin 
(BIL T), creatinine and urea levels in male rats weekly 
for 7 weeks, followed by a 14-day washout period 
indicating that there was no acute and/or subchronic 
damage32. In contrast, other studies showed that there 
was a significant increase in  serum ALT, AST 
activities and creatinine levels in rats i.p. injected with 
PEG-coated and uncoated GNPs at a dose of 12.5, 25, 
50, and 100 µg/kg body weight 33. This difference 
could be attributed to the higher dose used, the route of 
administration, or species difference. 
Furthermore, in the current study, i.m. injection of 
single or repeated injection of 75 μg of 10 or 50 nm 
GNPs/kg bwt has no significant effect on blood 
glucose level on Day-3 and 60 when compared to the 
control group. While in 10 nm GNPs treated male 
rats, blood glucose level was significantly higher on 
Day-7 post-injection when compared with the control 
group. Also, the present work showed that repeated 
injection of 10 nm or 50 nm GNPs significantly 
decreased blood glucose level on Day-60 post-
injection when compared to the control group. AuNPs 
have the anti-oxidative and anti-hyperglycemic 
activities of AuNPs in diabetic mice34. Conversely, an 
oral treatment of rats with 650 μg AuNPs/Kg daily  
for 14 days significantly elevated serum glucose 
concentration35. This difference could be attributed to 
the higher dose used particle size. 
For estimation of serum lipid profile i.m. injection of 
a single dose of GNPs at size 50 nm and 10 nm had no 
significant effect on serum TC, TAG, HDL, and non-
HDL cholesterol (LDL-VLDL) levels compared to the 
control group after 3 and 60 days, also, chronic 
administration of GNPs at both sizes had no significant 
effect on these parameters. However, a single dose of  
10 nm GNPs significantly elevated serum TC, TAG, and 
non-HDL cholesterol (LDL-VLDL) and significantly 
decreased serum HDL levels on Day-7 post-injection 
when compared to 50 nm GNPs or control groups. 
Similarly, administration of 2.5 mg of 20 nm GNPs/kg 
i.p. every 48 h or daily for 21 days has no changes in 
cholesterol and triglyceride levels in the liver and serum 
of GNPs treated rats compared to control group36. Also, 
there were no variations of serum levels of TC, TAG, 
LDL, VLDL, and HDL between AuNPs-treated mice 
and control group37. On the other hand, an oral dose of 
10 mg AuNPs/kg b.w given daily for 60 days induced a 
significant decrease of TC, TAG, and LDL-c levels and 
elevation of HDL-c levels compared with diabetic 
group38. This discrepancy could be due to difference  
in the protocol used for preparation, size, and dose  
of GNPs. 
For hematological analysis, i.m. injection of single 
or repeated doses of 10 nm and 50 nm GNPs has no 
significant effect on any of the tested hematological 
parameters such as RBC, HGB, PCV, MCV, MCH, 
MCHC, WBC, and PLT compared to the control group 
at each time point of the experiments. However, 
repeated doses of 50 nm GNPs significantly decreased 
blood platelets count on Day-60 post- injection when 
compared to the control group. These results are 
matched with other studies reported that the 
administration of AuNPs in rats daily for 14 
consecutive days had no significant effect on all 
hematological values as compared to control rats35. 
Also, the exposure to 4-5 nm AuNPs at different doses 
for 6 h/day, 5 days/week, for 90-days in a whole-body 
inhalation chamber had no significant changes in the 
hematology value compared to the control group6. In 
contrast, chronic administration of 0.45 mg or 90 mg 
PEG-AuNRs/kg bwt for 6 months significantly induced 
hematological changes in female and male rats. This 
reduction in platelet count might be due to platelet 
aggregation (clumping), which will reduce reported 
counts because clumps of platelets will not be counted 
with any automated hematology analyzers39. 
 
Conclusion 
Single or repeated i.m injection of 10 nm or 50 nm 
GNPs induced transit changes in liver and kidney 
functions, which retained to the normal value after  
60 days of injection. Also, repeated injection of 10 nm 
or 50 nm GNPs over 5 weeks showed a hypoglycemic 
effect in experimental animals.  
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